California State Teachers Retirement System cut its holdings in shares of Cabot Corporation (NYSE:CBT - Free Report) by 2.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 61,588 shares of the specialty chemicals company's stock after selling 1,781 shares during the quarter. California State Teachers Retirement System owned about 0.12% of Cabot worth $5,593,422 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. HB Wealth Management LLC acquired a new position in Cabot during the 2nd quarter worth approximately $239,000. Nykredit A S acquired a new position in shares of Cabot in the 2nd quarter valued at $254,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Cabot by 16.4% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 110,259 shares of the specialty chemicals company's stock worth $10,014,000 after buying an additional 15,561 shares during the period. Hsbc Holdings PLC raised its stake in shares of Cabot by 495.9% in the 2nd quarter. Hsbc Holdings PLC now owns 18,575 shares of the specialty chemicals company's stock valued at $1,690,000 after purchasing an additional 15,458 shares during the period. Finally, Empowered Funds LLC acquired a new position in Cabot in the 2nd quarter valued at about $3,147,000. Institutional investors and hedge funds own 93.18% of the company's stock.
Cabot Stock Down 1.1%
CBT stock traded down $0.91 during trading hours on Tuesday, reaching $79.85. 192,622 shares of the stock were exchanged, compared to its average volume of 462,411. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The firm's 50-day moving average is $85.72 and its 200-day moving average is $81.65. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The company has a market cap of $4.12 billion, a price-to-earnings ratio of 22.49, a PEG ratio of 10.46 and a beta of 0.83.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.
Cabot Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 11th. Investors of record on Friday, August 28th were issued a $0.4725 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.4%. Cabot's dividend payout ratio (DPR) is presently 53.24%.
Insider Activity at Cabot
In related news, CEO Sean Keohane sold 134,895 shares of the company's stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the sale, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold a total of 229,597 shares of company stock worth $19,646,746 in the last 90 days. Company insiders own 3.08% of the company's stock.
Analyst Ratings Changes
A number of research firms have recently weighed in on CBT. Truist Financial set a $100.00 target price on Cabot in a report on Wednesday, August 5th. Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an "underweight" rating in a report on Friday, August 7th. UBS Group cut their target price on Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a report on Friday, August 21st. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $89.00.
Check Out Our Latest Analysis on Cabot
Cabot Profile
(
Free Report)
Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company. Its products are used by manufacturers in transportation, infrastructure, energy, electronics, consumer goods, and other industrial markets.
Cabot's Reinforcement Materials business produces carbon black and other materials used to reinforce tires, automotive components, industrial rubber products, and plastics. Its Performance Chemicals business supplies specialty carbon blacks, fumed metal oxides, inkjet colorants, conductive compounds, masterbatch products, and related materials used to modify the color, conductivity, strength, durability, and processing characteristics of finished products.
Founded in 1882, Cabot operates research, manufacturing, and commercial facilities serving customers in North America, South America, Europe, Asia, and other international markets.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.